← Leaderboards
Fengyi Wan
Johns Hopkins University
$4,781,422
Attributed
$4,781,422
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $655.9K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,781,422 · 4
By mechanism
R01$3,621,014 · 2
R00$710,095 · 1
R21$450,313 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Vincent W. Yang$29,529,911
- Sinisa Urban$8,866,210
- Kenneth D. Karlin$16,339,237
- Pierre Coulombe$26,047,228
- Arturo Casadevall$47,974,076
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionPlaySiteSignal PathwayProteinsMolecularLeadNovel StrategiesMalignant NeoplasmsColonCancer TherapyRegulationAnimalsResponseAttenuatedCell PhysiologyCellsPublic Health RelevanceLaboratoriesMitosisDna DamageRadiation TherapyGenotoxicityPoly(Adp-Ribose) Polymerases
Grant awards (18)
Targeting the Sam68-stimulated PARP1 activation for cancer treatment$315,833
R01 · FY2025 · CA · contact PI
Targeting the Sam68-stimulated PARP1 activation for cancer treatment$364,073
R01 · FY2024 · CA · contact PI
Targeting the Sam68-stimulated PARP1 activation for cancer treatment$375,569
R01 · FY2023 · CA · contact PI
Targeting the Sam68-stimulated PARP1 activation for cancer treatment$135,358
R01 · FY2021 · CA · contact PI
Targeting the Sam68-stimulated PARP1 activation for cancer treatment$451,191
R01 · FY2020 · CA · contact PI
Site-specific DNA recombinase and A/E pathogen virulence$204,688
R21 · FY2020 · AI · contact PI
PARylation in genotoxic stress-induced NF-kB activation$311,850
R01 · FY2019 · GM · contact PI
Site-specific DNA recombinase and A/E pathogen virulence$245,625
R21 · FY2019 · AI · contact PI
PARylation in genotoxic stress-induced NF-kB activation$311,850
R01 · FY2018 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation$364,597
R01 · FY2017 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation Supplement for Research on Sex/Gender Influences$104,586
R01 · FY2017 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation$390,962
R01 · FY2016 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation - Supplement for Equipment$156,921
R01 · FY2016 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation Supplement$26,374
R01 · FY2016 · GM · contact PI
PARylation in genotoxic stress-induced NF-kB activation$311,850
R01 · FY2015 · GM · contact PI
Novel Subunit of NF-kB Confers Gene Regulatory Specificity$227,037
R00 · FY2013 · CA · contact PI
Novel Subunit of NF-kB Confers Gene Regulatory Specificity$241,528
R00 · FY2012 · CA · contact PI
Novel Subunit of NF-kB Confers Gene Regulatory Specificity$241,530
R00 · FY2011 · CA · contact PI